Yissum Announces The Discovery Of A Novel Small Molecule With Potent Anti-Metastatic Activity
Mar 3rd 2008Drug InformationCancer
Yissum Ltd., the Technology Transfer Company of the Hebrew University of Jerusalem, today announced that scientists from the School of Pharmacy at the Hebrew University of Jerusalem discovered a novel orally available drug that prevents metastasis formation in various types of cancers.
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
